{"database": "lobbying", "table": "lobbying_activities", "rows": [[1545835, "65a2174b-c80e-49ae-a089-d2cb12af6016", "Q2", "CHAMBER HILL STRATEGIES", 400645947, "AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL)", 2014, "second_quarter", "PHA", "Implementation issues related to P.L. 113-54, the Drug Quality and Security Act", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2014-07-02T13:00:18.497000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1545835"], "units": {}, "query_ms": 51.39159795362502, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}